Jose O. Latino

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study.

Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study.

Journal: Lupus

Published: December 24, 2025

Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome.

Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: November 11, 2025

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality.

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality.

Journal: Clinical rheumatology

Published: September 01, 2023

Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.

Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.

Journal: Lupus

Published: February 14, 2022

Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.

Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.

Journal: Lupus

Published: August 26, 2020

In utero exposure to Azathioprine in autoimmune disease. Where do we stand?

In utero exposure to Azathioprine in autoimmune disease. Where do we stand?

Journal: Autoimmunity reviews

Published: January 21, 2020

A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome.

A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome.

Journal: Immunologic research

Published: December 25, 2019

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

Journal: Immunologic research

Published: August 31, 2018

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Journal: Autoimmunity reviews

Published: May 19, 2018

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Journal: Thrombosis and haemostasis

Published: March 01, 2018

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.

Journal: Journal of assisted reproduction and genetics

Published: November 07, 2017

Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort.

Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort.

Journal: Medicina clinica

Published: September 29, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026